• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR Back to Search Results
Model Number G247
Device Problems Over-Sensing (1438); Pacing Problem (1439); High Capture Threshold (3266)
Patient Problems Undesired Nerve Stimulation (1980); Asystole (4442)
Event Date 04/08/2023
Event Type  malfunction  
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded episodes with far field over sensing of the atrial pacing on the right ventricular (rv) lead channel.There was pacing inhibition of more than 3 seconds in the presenting electrogram.Various reprogramming options were completed, and the pacing inhibition was reduced.Other programming options were recommended as well as a defibrillation threshold (dft) test and a chest x ray to confirm lead location.The patient is pacing dependent, and the crt-d remains in service.No additional adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded episodes with far field over sensing of the atrial pacing on the right ventricular (rv) lead channel.There was pacing inhibition of more than 3 seconds in the presenting electrogram.Various reprogramming options were completed, and the pacing inhibition was reduced.Other programming options were recommended as well as a defibrillation threshold (dft) test and a chest x ray to confirm lead location.The patient is pacing dependent, and the crt-d remains in service.No additional adverse patient effects were reported.Additional information was received mentioning that false atrial tachy response episodes were recorded with what appears to be far field r wave over sensing post ventricular pacing.The pacing thresholds were high in different coils of the left ventricular (lv) lead.Also, an impedance jump was observed but this was expected behavior due to the surface area size difference.The patient referred feeling some intensity in the pacing.Various reprogramming options were recommended.The crt-d and the lv lead remains in service.No adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIGILANT X4 CRT-D
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16851733
MDR Text Key314351806
Report Number2124215-2023-21035
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589287
UDI-Public00802526589287
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberG247
Device Catalogue NumberG247
Device Lot Number302172
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/11/2023
Initial Date FDA Received05/02/2023
Supplement Dates Manufacturer Received05/30/2023
Supplement Dates FDA Received06/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/10/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age59 YR
Patient SexMale
-
-